Mesalazine enteric-coated tablets combined with retention enema for symptom alleviation in mild to moderate E2-type active ulcerative colitis: A retrospective comparative cohort study.

Zhang R, Wang S, Yang M, Yang C, Yang D, Zhao Y, Zhang X

Open source

DOI
10.36721/pjps.2026.39.12.332.1
Published
2026 Dec 1
Container
Pakistan journal of pharmaceutical sciences
Publisher
Not recorded
Open access
no

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.36721/pjps.2026.39.12.332.1,
  title = {Mesalazine enteric-coated tablets combined with retention enema for symptom alleviation in mild to moderate E2-type active ulcerative colitis: A retrospective comparative cohort study.},
  author = {Zhang R and Wang S and Yang M and Yang C and Yang D and Zhao Y and Zhang X},
  year = {2026},
  journal = {Pakistan journal of pharmaceutical sciences},
  doi = {10.36721/pjps.2026.39.12.332.1},
  url = {https://doi.org/10.36721/pjps.2026.39.12.332.1}
}

RIS

TY  - JOUR
TI  - Mesalazine enteric-coated tablets combined with retention enema for symptom alleviation in mild to moderate E2-type active ulcerative colitis: A retrospective comparative cohort study.
AU  - Zhang R
AU  - Wang S
AU  - Yang M
AU  - Yang C
AU  - Yang D
AU  - Zhao Y
AU  - Zhang X
PY  - 2026
JO  - Pakistan journal of pharmaceutical sciences
DO  - 10.36721/pjps.2026.39.12.332.1
UR  - https://doi.org/10.36721/pjps.2026.39.12.332.1
ER  - 

APA

R, Z., S, W., M, Y., C, Y., D, Y., Y, Z., & X, Z. (2026). Mesalazine enteric-coated tablets combined with retention enema for symptom alleviation in mild to moderate E2-type active ulcerative colitis: A retrospective comparative cohort study.. Pakistan journal of pharmaceutical sciences. https://doi.org/10.36721/pjps.2026.39.12.332.1

Source records